BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28379313)

  • 21. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
    Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
    Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
    van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
    Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
    Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
    J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation.
    Palmiter KA; Kitada Y; Muthuchamy M; Wieczorek DF; Solaro RJ
    J Biol Chem; 1996 May; 271(20):11611-4. PubMed ID: 8662805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tropomyosin pseudo-phosphorylation results in dilated cardiomyopathy.
    Rajan S; Jagatheesan G; Petrashevskaya N; Biesiadecki BJ; Warren CM; Riddle T; Liggett S; Wolska BM; Solaro RJ; Wieczorek DF
    J Biol Chem; 2019 Feb; 294(8):2913-2923. PubMed ID: 30567734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
    Robinson P; Griffiths PJ; Watkins H; Redwood CS
    Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants.
    Westfall MV; Borton AR; Albayya FP; Metzger JM
    Circ Res; 2002 Sep; 91(6):525-31. PubMed ID: 12242271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.
    Vikhorev PG; Vikhoreva NN; Yeung W; Li A; Lal S; Dos Remedios CG; Blair CA; Guglin M; Campbell KS; Yacoub MH; de Tombe P; Marston SB
    Cardiovasc Res; 2022 Jan; 118(1):241-253. PubMed ID: 33135063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
    Robinson P; Mirza M; Knott A; Abdulrazzak H; Willott R; Marston S; Watkins H; Redwood C
    J Biol Chem; 2002 Oct; 277(43):40710-6. PubMed ID: 12186860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-tropomyosin mutations in inherited cardiomyopathies.
    Redwood C; Robinson P
    J Muscle Res Cell Motil; 2013 Aug; 34(3-4):285-94. PubMed ID: 24005378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Biased β-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy.
    Ryba DM; Li J; Cowan CL; Russell B; Wolska BM; Solaro RJ
    Circulation; 2017 Mar; 135(11):1056-1070. PubMed ID: 28104714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts.
    Powers JD; Kooiker KB; Mason AB; Teitgen AE; Flint GV; Tardiff JC; Schwartz SD; McCulloch AD; Regnier M; Davis J; Moussavi-Harami F
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32931484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac actin capping protein reduction and protein kinase C inhibition maintain myofilament function during cardioplegic arrest.
    Yang FH; Pyle WG
    Cell Physiol Biochem; 2011; 27(3-4):263-72. PubMed ID: 21471715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling.
    Bardswell SC; Cuello F; Rowland AJ; Sadayappan S; Robbins J; Gautel M; Walker JW; Kentish JC; Avkiran M
    J Biol Chem; 2010 Feb; 285(8):5674-82. PubMed ID: 20018870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?
    Dweck D; Hus N; Potter JD
    J Biol Chem; 2008 Nov; 283(48):33119-28. PubMed ID: 18820258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structural basis of alpha-tropomyosin linked (Asp230Asn) familial dilated cardiomyopathy.
    Lynn ML; Tal Grinspan L; Holeman TA; Jimenez J; Strom J; Tardiff JC
    J Mol Cell Cardiol; 2017 Jul; 108():127-137. PubMed ID: 28600229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress.
    Wilkinson R; Song W; Smoktunowicz N; Marston S
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1936-46. PubMed ID: 26432839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.
    Vikhorev PG; Song W; Wilkinson R; Copeland O; Messer AE; Ferenczi MA; Marston SB
    Biophys J; 2014 Nov; 107(10):2369-80. PubMed ID: 25418306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.